Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures

被引：0

作者：

Mendler, Jason H. ^{[1
]}

Maharry, Kati ^{[1
]}

Radmacher, Michael D. ^{[1
]}

Mrozek, Krzysztof ^{[1
]}

Kohlschmidt, Jessica ^{[1
]}

Nicolet, Deedra ^{[1
]}

Becker, Heiko ^{[1
]}

Metzeler, Klaus H. ^{[1
]}

Schwind, Sebastian ^{[1
]}

Whitman, Susan P. ^{[1
]}

Blum, William ^{[1
]}

Powell, Bayard L. ^{[2
]}

Kolitz, Jonathan E. ^{[3
]}

Carter, Thomas H. ^{[4
]}

Wetzler, Meir ^{[5
]}

Moore, Joseph O. ^{[6
]}

Carroll, Andrew J. ^{[7
]}

Baer, Maria R. ^{[8
]}

Larson, Richard A. ^{[9
]}

Caligiuri, Michael A. ^{[1
]}

Marcucci, Guido ^{[10
]}

Bloomfield, Clara D. ^{[1
]}

机构：

[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[2] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA

[3] N Shore Long Isl Jewish Hlth Syst, Dept Med, Lake Success, NY USA

[4] Univ Iowa, Iowa City, IA USA

[5] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[6] Duke Univ, Med Ctr, Durham, NC USA

[7] Univ Alabama, Dept Genet, Birmingham, AL USA

[8] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA

[9] Univ Chicago, Chicago, IL 60637 USA

[10] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1476 / 1477

页数：2

共 43 条

[21] Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients
Butrym, Aleksandra
Rybka, Justyna
Baczynska, Dagmara
Tukiendorf, Andrzej
Kuliczkowski, Kazimierz
Mazur, Grzegorz
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
[22] Increased Expression of Macrophage Migration Inhibitory Factor (MIF) Receptor CD74 Is Associated with Inferior Outcome in Younger Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML): a Cancer and Leukemia Group B (CALGB) Study.
Attar, Eyal C.
Maharry, Kati
Mrozek, Krzysztof
Radmacher, Michael D.
Whitman, Susan P.
Paschka, Peter
Langer, Christian
Holland, Kelsi B.
Powell, Bayard L.
Kolitz, Jonathan E.
Carroll, Andrew J.
Larson, Richard A.
Marcucci, Guido
Bloomfield, Clara D.
BLOOD, 2009, 114 (22) : 645 - 646
[23] HIGH EXPRESSION OF DNMT3B NEGATIVELY IMPACTS ON CLINICAL OUTCOME OF OLDER PATIENTS (PTS) WITH PRIMARY CYTOGENETICALLY NORMAL (CN) ACUTE MYELOID LEUKEMIA (AML) [CALGB 20202 (ALLIANCE)]
Niederwieser, C.
Kohlschmidt, J.
Maharry, K.
Mrozek, K.
Metzeler, K.
Volinia, S.
Yan, P.
Frankhouser, D.
Whitman, S.
Becker, H.
Eisfeld, A.
Schwind, S.
Curfman, J.
Wu, Y.
Baer, M.
Powell, B.
Kolitz, J.
Moore, J.
Carter, T.
Marcucci, G.
Bloomfield, C.
HAEMATOLOGICA, 2013, 98 : 484 - 484
[24] Uniparental Disomies (UPD) of Chromosome 13q Is Associated with Shorter Disease-Free Survival in Adult Patients (Pts) with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
Walker, Christopher J.
Kohlschmidt, Jessica
Eisfeld, Ann-Kathrin
Mrozek, Krzysztof
Nicolet, Deedra
Blachly, James S.
Oakes, Christopher C.
Orwick, Shelley
Papaioannou, Dimitrios
Powell, Bayard L.
Kolitz, Jonathan E.
Carroll, Andrew J.
Stone, Richard M.
Byrd, John C.
de la Chapelle, Albert
Bloomfield, Clara D.
BLOOD, 2018, 132
[25] RUNX1 Mutation is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia (AML) who Received Allogeneic Stem Cell Transplantation (allo-SCT)
Chan, Onyee
Jennings, Michelle
Asghari, Hannah
Song, Jinming
Hussaini, Mohammad
Sallman, David
Padron, Eric
Komrokji, Rami
List, Alan
Lancet, Jeffrey
Mishra, Asmita
Sweet, Kendra
Talati, Chetasi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S233 - S233
[26] High BAALC expression associates with other molecular prognostic markers, poor outcome and a distinct gene expression signature in cytogenetically normal acute myeloid leukemia (CN AML): A Cancer and Leukemia Group B (CALGB) study
Langer, C.
Ruppert, A. S.
Radmacher, M. D.
Whitman, S. P.
Paschka, P.
Baldus, C. D.
Mrozek, K.
Kolitz, J. E.
Marcucci, G.
Bloomfield, C. D.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[27] Gene and microRNA (miRNA) expression signatures and prognostic significance of CEBPA mutations in cytogenetically normal (CN) acute myeloid leukemia (AML)with high-risk molecular features:: A cancer and leukemia group B (CALGB) study
Marcucci, Guido
Maharry, Kati
Radmacher, Michael D.
Mrozek, Krzysztof
Vukosavljevic, Tamara
Paschka, Peter
Whitman, Susan P.
Langer, Christian
Baldus, Claudia D.
Ruppert, Amy S.
Powell, Bayard L.
Carroll, Andrew J.
Caligiuri, Michael A.
Kolitz, Jonathan E.
Larson, Richard A.
Bloomfield, Clara D.
BLOOD, 2007, 110 (11) : 39A - 39A
[28] High BAALC Expression in Cytogenetically Normal Acute Myeloid Leukemia Strongly Correlates with Adverse Markers Such As RUNX1mut, MLL-PTD and FLT3-ITD and Is Useful for Disease Monitoring
Weber, Simone
Alpermann, Tamara
Eder, Christiane
Dicker, Frank
Jeromin, Sabine
Kohlmann, Alexander
Fasan, Annette
Haferlach, Claudia
Kern, Wolfgang
Haferlach, Torsten
Schnittger, Susanne
BLOOD, 2012, 120 (21)
[29] Mutated Nucleophosmin 1 (NPM1) Is an Immunogenic Target and Patients with NPM1mut Acute Myeloid Leukemia (AML) Showed High Expression of Different Leukemia-Associated Antigens (LAAs)
Hofmann, Susanne
Schneider, Vanessa
Bullinger, Lars
Ono, Yoko
Schmitt, Anita
Zhang, Lu
Goetz, Marlies
Doehner, Konstanze
Mytilineos, Joannis
Wiesneth, Markus
Doehner, Hartmut
Schmitt, Michael
Greiner, Jochen
BLOOD, 2012, 120 (21)
[30] Prognostic Importance of MN1 Transcript Levels, and Biologic Insights From MN1-Associated Gene and MicroRNA Expression Signatures in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Langer, Christian
Marcucci, Guido
Holland, Kelsi B.
Radmacher, Michael D.
Maharry, Kati
Paschka, Peter
Whitman, Susan P.
Mrozek, Krzysztof
Baldus, Claudia D.
Vij, Ravi
Powell, Bayard L.
Carroll, Andrew J.
Kolitz, Jonathan E.
Caligiuri, Michael A.
Larson, Richard A.
Bloomfield, Clara D.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3198 - 3204

← 1 2 3 4 5 →